intravitreal triamcinolone for refractory diabetic macular edema: a randomized climical trial

نویسندگان

محمدحسین دهقان

mh dehghan تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم حمید احمدیه

h ahmadieh تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم علیرضا رمضانی

ar ramezani تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم مرتضی انتظاری

m entezari تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم آرش انیسیان

چکیده

purpose: to evaluate the effect of intravitreal triamcinolone acetonide (ivt) on clinical, angiographic, and optical coherence tomographic parameters in refractory diabetic macular edema (dme). methods: in a double-masked placebo-controlled randomized clinical trial, 88 eyes of 61 patients with dme refractory to previous laser therapy or not suitable for such treatment were included in the study. eligible eyes were randomly assigned into two groups. the treatment group (45 eyes) received 4 mg ivt and the placebo group (43 eyes) received subconjunctival injection of placebo. complete ophthalmologic examination, fluorescein angiography, and optical coherence tomography (oct) were performed before intervention and repeated after 2 and 4 months. quantitative measurement of variables on angiograms including hard exudates (he), size of foveal avascular zone, and leakage severity was performed using photoshop software.   results: two months after intervention, visual acuity (va) improved in the treatment group (-0.13 logmar, p=0.01) but slightly deteriorated in the placebo group (0.02 logmar, p=0.63). the difference of the above changes (0.15 logmar) was statistically significant at 2 months (p=0.02) but reduced to 0.11 logmar (p=0.08) after 4 months. mean (standard deviation) of central macular thickness (cmt) by oct before and 2 and 4 months after injection was 393 (151), 293 (109), and 362 (119) microns in the treatment group and 393 (166), 404 (134), and 405 (160) microns in the placebo group, respectively. the second month difference was statistically significant (p=0.01). reduction of the amount of he (51%, p=0.004) and petaloid pattern (p=0.012) was significant in the treatment group as compared with the placebo group. there was no significant ivt-related side effects except for transient ocular hypertension in 32.6% of patients after 2 months. conclusion: the greatest therapeutic effect of ivt on dme according to cmt and va occurs at 2 months and decreases up to the fourth month. however, concerning cyctoid macular edema and hard exudates, the effect is maintained up to 4 months.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Intravitreal Triamcinolone Reinjection for Refractory Diabetic Macular Edema

PURPOSE To evaluate the effect of intravitreal triamcinolone acetonide (IVT) reinjection on clinical and optical coherence tomographic features in refractory diabetic macular edema. METHODS In a prospective interventional case series, all IVT treated patients enrolled in a previous clinical trial were recalled to have a new ophthalmologic examination and optical coherence tomography (OCT) per...

متن کامل

intravitreal triamcinolone for treatment of refractory diabetic macular edema

purpose: to determine if intravitreal injection of triamcinolone acetonide is safe and effective in the treatment of diabetic macular edema unresponsive to prior laser photocoagulation. methods: fifty-four eyes of 38 patients with clinically significant macular edema which had received at least two sessions of laser photocoagulation according to early treatment diabetic retinopathy study guidel...

متن کامل

reinjection of intravitreal triamcinolone for refractory diabetic macular edema

purpose: to evaluate the effect of intravitreal triamcinolone acetonide (ivt) reinjection on clinical and optical coherence tomographic (oct) features in refractory diabetic macular edema (dme). methods: in an interventional case series, all ivt-treated patients enrolled in a previous clinical trial (45 subjects), were recalled for performing a new ophthalmologic examination and oct. suitable e...

متن کامل

A randomized trial comparing intravitreal triamcinolone and focal/grid photocoagulation for diabetic macular edema: baseline features.

PURPOSE To compare baseline demographic, systemic, and ocular characteristics within age and racial subgroups among participants in this Diabetic Retinopathy Clinical Research Network clinical trial and to compare this cohort with other cohorts enrolled in phase 3 clinical trials for diabetic retinopathy. METHODS Thirty-six month, randomized, controlled, multicenter clinical trial of 693 part...

متن کامل

A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

OBJECTIVE To evaluate the efficacy and safety of 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone in comparison with focal/grid photocoagulation for the treatment of diabetic macular edema (DME). DESIGN Multicenter, randomized clinical trial. PARTICIPANTS Eight hundred forty study eyes of 693 subjects with DME involving the fovea and with visual acuity of 20/40 to 20/320....

متن کامل

Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial.

PURPOSE To compare the effectiveness of posterior sub-Tenon's infusion (STi) and intravitreal injection (IVI) of triamcinolone acetonide (TA) for treatment of refractory diffuse diabetic macular edema. METHODS Thirty-six phakic diabetic patients with refractory diffuse diabetic macular edema were prospectively enrolled. Patients randomly received either 40 mg STi or 4 mg IVI of TA. Comprehens...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
بینا

جلد ۱۰، شماره ۳، صفحات ۲۸۲-۳۰۱

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023